ZONEONE-PHARMA - Key Persons

Job Titles:

• President
• Founding Scientist, President

A founding partner in ZoneOne Pharma, Dr. Noble has served as President since 2011, handling operations, leading cancer therapeutic development projects, contributing to the chelator project and developing methods to evaluate generic liposome formulations in collaboration with the FDA. He has studied nanostructures and drug delivery for the majority of his career, and is known for his dedication and creative problem-solving. As a Senior Scientist at Merrimack Pharmaceuticals (formerly Hermes Biosciences), Dr. Noble was a key team member in both the discovery and development of Onivyde®, which was recently approved for pancreatic cancer, one of the most intractable cancers. He was also a member of the manufacturing and quality control teams during development of an anti-Her2 immunoliposomal doxorubicin (MM-302). Dr. Noble's doctoral candidate studies on redox-responsive dendrimers at Louisiana State University, for which he earned a Ph.D. in Chemistry in 2001, and his postdoctoral work on antibody-targeted immunoliposomes and drug delivery to brain tumors at the University of California San Francisco, laid the foundation for future discoveries and achievements. When he's not working toward the next breakthrough in drug delivery, you can find Charles on the ski slopes or surfing.

Job Titles:

• Chairman of the Board
• Co - Founder
• Chairman of the Board - Click Here to Read Bio
• Co - Founder and Chairman of the Board of Z1P

Frank is co-founder and Chairman of the Board of Z1P. He also serves as a faculty member at UCSF in the Department of Bioengineering & Therapeutics. He pioneered many liposome and drug delivery technologies and has an extensive publication and patent record in these fields. He co-founded SEQUUS which introduced the first liposome based oncology product, DOXIL® which was approved in 1995 for the treatment of Kaposi's sarcoma and was part of the team that devised the antifungal drug Amphotec® and manufacturing methods. Frank also founded a gene therapy company called GeneMedicine.

Job Titles:

• Board Member - Click Here to Read Bio

Job Titles:

• Board Director
• Board Member - Click Here to Read Bio.

Job Titles:

• Project Manager
• Project Manager at ZoneOne Pharma

Job Titles:

• Research Scientist

Zhipeng holds a Ph.D. in Biochemistry and Molecular Biology. He is leading chemistry development of early drug candidates, conducting in vitro liposomal drug release, and investigating liposome-antibody interaction. In his spare time he likes hiking, fishing and collecting antiques.